MedTrace Logo

Role of Beta-blockers in the Prevention on the Arisen of a Severe Sepsis (TESS)

NCT01606631 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2444

Last updated 2012-05-28

No results posted yet for this study

Summary

The severe sepsis (SS) and toxic shock (TS) are both frequent and severe complications of infectious diseases. They are one of the top ten causes of death in industrialized countries. But an eventual protective role of beta-blockers (anti-hypertensive drug) in their occurrence on a community infection has never been studied. The objective of this study is to evaluate this role.

Conditions

  • Community-Acquired Infections

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Bellissant Eric, MD, PhD · Rennes University Hospital - CIC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01606631 on ClinicalTrials.gov